SitesBLAST
Comparing WP_066328676.1 NCBI__GCF_900100165.1:WP_066328676.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
O81852 Bifunctional aspartokinase/homoserine dehydrogenase 2, chloroplastic; AK-HD 2; AK-HSDH 2; Beta-aspartyl phosphate homoserine 2; EC 2.7.2.4; EC 1.1.1.3 from Arabidopsis thaliana (Mouse-ear cress) (see paper)
32% identity, 100% coverage: 1:800/803 of query aligns to 89:909/916 of O81852
- I441 (= I335) mutation to A: Loss of threonine sensitivity for the aspartokinase activity and decreased inhibition of homoserine dehydrogenase activity by threonine.
- Q443 (= Q337) mutation to A: Loss of threonine sensitivity for the aspartokinase activity and decreased inhibition of homoserine dehydrogenase activity by threonine.
- I522 (≠ F412) mutation to A: No effect on the inhibition of aspartokinase activity by threonine, but decreased inhibition of homoserine dehydrogenase activity by threonine.
- Q524 (≠ N414) mutation to A: No effect on the inhibition of aspartokinase activity by threonine, but decreased inhibition of homoserine dehydrogenase activity by threonine.
2hmfA Structure of a threonine sensitive aspartokinase from methanococcus jannaschii complexed with mg-adp and aspartate (see paper)
37% identity, 49% coverage: 3:392/803 of query aligns to 3:408/464 of 2hmfA
- binding adenosine-5'-diphosphate: G7 (= G7), T229 (= T215), D230 (≠ H216), V231 (= V217), Y235 (= Y221), T237 (≠ A223), D238 (≠ N224), P239 (= P225), R240 (≠ D226), K265 (≠ T251), V266 (≠ I252)
- binding aspartic acid: S39 (= S39), T45 (= T45), F192 (= F178), R206 (= R192), G207 (≠ N193), S209 (= S195)
3c1nA Crystal structure of allosteric inhibition threonine-sensitive aspartokinase from methanococcus jannaschii with l-threonine (see paper)
37% identity, 49% coverage: 3:392/803 of query aligns to 3:403/458 of 3c1nA
Sites not aligning to the query:
3c1mC Cyrstal structure of threonine-sensitive aspartokinase from methanococcus jannaschii with mgamp-pnp and l-aspartate (see paper)
36% identity, 49% coverage: 3:392/803 of query aligns to 3:412/468 of 3c1mC
- binding phosphoaminophosphonic acid-adenylate ester: K5 (= K5), G7 (= G7), G8 (= G8), S39 (= S39), T229 (= T215), D230 (≠ H216), Y235 (= Y221), D238 (≠ N224), P239 (= P225), R240 (≠ D226), K265 (≠ T251), V266 (≠ I252)
- binding aspartic acid: T45 (= T45), E129 (= E114), F192 (= F178), R206 (= R192), G207 (≠ N193), S209 (= S195)
O94671 Homoserine dehydrogenase; HDH; HSD; EC 1.1.1.3 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
37% identity, 44% coverage: 448:799/803 of query aligns to 8:364/376 of O94671
- S201 (≠ P635) modified: Phosphoserine
1tveA Homoserine dehydrogenase in complex with 4-(4-hydroxy-3- isopropylphenylthio)-2-isopropylphenol (see paper)
37% identity, 45% coverage: 445:802/803 of query aligns to 2:357/358 of 1tveA
1q7gA Homoserine dehydrogenase in complex with suicide inhibitor complex NAD-5-hydroxy-4-oxonorvaline (see paper)
37% identity, 45% coverage: 445:802/803 of query aligns to 2:357/358 of 1q7gA
- active site: D218 (= D661), K222 (= K665)
- binding nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline: G13 (= G456), V14 (≠ L457), V15 (= V458), E39 (≠ N488), N91 (= N536), T92 (= T537), S93 (≠ A538), I97 (≠ F542), P114 (≠ S559), K116 (= K561), A143 (≠ T589), S173 (= S619), K222 (= K665), A338 (= A783), T343 (= T788)
1ebuD Homoserine dehydrogenase complex with NAD analogue and l-homoserine (see paper)
37% identity, 45% coverage: 445:802/803 of query aligns to 2:357/358 of 1ebuD
- active site: D218 (= D661), K222 (= K665)
- binding 3-aminomethyl-pyridinium-adenine-dinucleotide: G11 (= G454), A12 (≠ H455), G13 (= G456), V14 (≠ L457), V15 (= V458), E39 (≠ N488), A40 (≠ S489), N91 (= N536), S93 (≠ A538), K116 (= K561), T343 (= T788)
1ebfA Homoserine dehydrogenase from s. Cerevisiae complex with NAD+ (see paper)
37% identity, 45% coverage: 445:802/803 of query aligns to 2:357/358 of 1ebfA
- active site: D218 (= D661), K222 (= K665)
- binding nicotinamide-adenine-dinucleotide: I10 (≠ F453), A12 (≠ H455), G13 (= G456), V14 (≠ L457), V15 (= V458), E39 (≠ N488), A40 (≠ S489), T92 (= T537), S93 (≠ A538), P114 (≠ S559)
P31116 Homoserine dehydrogenase; HDH; HSD; EC 1.1.1.3 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see 3 papers)
37% identity, 45% coverage: 445:802/803 of query aligns to 3:358/359 of P31116
- A13 (≠ H455) binding NAD(+)
- V15 (≠ L457) binding NAD(+)
- V16 (= V458) binding NAD(+)
- A41 (≠ S489) binding NAD(+)
- H79 (≠ Y522) mutation to A: Reduces kcat 2-fold.
- T93 (= T537) binding NAD(+)
- K117 (= K561) mutation to A: Loss of activity.
- E143 (= E588) binding Na(+)
- V146 (= V591) binding Na(+)
- A148 (= A593) binding Na(+)
- L150 (= L595) binding Na(+)
- E208 (= E650) binding L-homoserine; mutation to D: Increases KM for aspartate-semialdehyde 48-fold and reduces kcat by 50%.; mutation E->L,Q: Loss of activity.
- D219 (= D661) binding L-homoserine; mutation to L: Reduces kcat 150-fold.
- K223 (= K665) mutation to V: Loss of activity.
- H309 (≠ V748) mutation to A: Reduces kcat 40-fold. Affects dimer formation.
- G340 (= G784) binding NAD(+)
2cdqA Crystal structure of arabidopsis thaliana aspartate kinase complexed with lysine and s- adenosylmethionine (see paper)
28% identity, 55% coverage: 3:442/803 of query aligns to 6:459/470 of 2cdqA
- binding lysine: S40 (= S39), A41 (= A40), T46 (= T45), E124 (= E114), M327 (≠ L311), Q330 (≠ K314), F333 (≠ V317), L334 (≠ D318), S347 (= S331), V348 (= V332), D349 (≠ S333)
- binding s-adenosylmethionine: G345 (≠ N329), I346 (= I330), S347 (= S331), W368 (≠ A353), S369 (≠ T354), R370 (≠ K355), L372 (≠ M357), E376 (= E361)
2j0xA Crystal structure of e. Coli aspartokinase iii in complex with lysine and aspartate (t-state) (see paper)
29% identity, 48% coverage: 5:393/803 of query aligns to 6:395/447 of 2j0xA
- binding aspartic acid: F182 (= F178), G197 (≠ N193), G198 (= G194), S199 (= S195), D200 (≠ N196)
- binding lysine: M316 (≠ L311), S319 (≠ K314), F322 (≠ V317), L323 (≠ D318), S336 (= S331), V337 (= V332), D338 (≠ S333), S343 (= S340), E344 (= E341)
2j0wA Crystal structure of e. Coli aspartokinase iii in complex with aspartate and adp (r-state) (see paper)
29% identity, 48% coverage: 5:393/803 of query aligns to 6:395/447 of 2j0wA
- binding adenosine-5'-diphosphate: T219 (= T215), D220 (≠ H216), I224 (= I220), Y225 (= Y221), D228 (≠ N224), R230 (≠ D226), K255 (≠ T251), V256 (≠ I252)
- binding aspartic acid: S37 (= S39), T43 (= T45), E117 (= E114), F182 (= F178), R196 (= R192), G197 (≠ N193), S199 (= S195)
P08660 Lysine-sensitive aspartokinase 3; Aspartate kinase III; AKIII; Lysine-sensitive aspartokinase III; EC 2.7.2.4 from Escherichia coli (strain K12) (see paper)
29% identity, 48% coverage: 5:393/803 of query aligns to 8:397/449 of P08660
- K8 (= K5) mutation to R: Reduces activity about 98%. Increases KM for aspartate about 40-fold, enzyme is less sensitive to lysine inhibition.
- E119 (= E114) mutation to D: Increases KM for aspartate about 3000-fold.
- R198 (= R192) mutation to K: Increases KM for aspartate about 200-fold.
- D202 (≠ N196) mutation to E: Reduces activity about 98%. Increases KM for aspartate about 40-fold, enzyme is less sensitive to lysine inhibition.
P10869 Aspartokinase; Aspartate kinase; EC 2.7.2.4 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see 3 papers)
24% identity, 57% coverage: 3:457/803 of query aligns to 16:515/527 of P10869
- K18 (= K5) mutation K->R,A,Q: Reduces kcat.
- G25 (≠ S12) mutation to D: Decreases affinity for aspartate and ATP.
- K26 (≠ N13) mutation to I: Decreases affinity for aspartate and ATP.
- E254 (≠ H216) mutation to A: Reduces kcat.
- E279 (= E241) mutation to A: Reduces kcat and affects inhibition by threonine.
- H292 (= H254) mutation to A: Reduces kcat.
- A406 (≠ G345) mutation to T: Decreases enzyme stability.
- R419 (≠ I358) mutation to A: Reduces kcat.
- G452 (vs. gap) mutation to D: Disrupts threonine binding.
- H497 (= H438) mutation to A: Reduces kcat.
O60163 Aspartokinase; Aspartate kinase; EC 2.7.2.4 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
24% identity, 55% coverage: 3:442/803 of query aligns to 17:495/519 of O60163
- S326 (vs. gap) modified: Phosphoserine
- T328 (vs. gap) modified: Phosphothreonine
P61489 Aspartokinase; Aspartate kinase; AK; ASK; Threonine-sensitive AK; ThrA; EC 2.7.2.4 from Thermus thermophilus (see paper)
27% identity, 49% coverage: 3:394/803 of query aligns to 5:351/405 of P61489
- K7 (= K5) mutation to A: Loss of aspartokinase activity.; mutation to M: Loss of aspartokinase activity.
- G9 (= G7) mutation to M: Loss of aspartokinase activity.
- G10 (= G8) mutation to A: Significant decrease in the catalytic efficiency.
- S41 (= S39) mutation to A: Significant decrease in the catalytic efficiency. Requires higher concentration of magnesium ion than wild-type.
- A42 (= A40) mutation to S: Loss of aspartokinase activity.
- T47 (= T45) mutation to A: Significant decrease in the affinity for aspartic acid. Requires higher concentration of magnesium ion than wild-type.
- E74 (= E114) mutation to A: Loss of aspartokinase activity.; mutation to Q: Loss of aspartokinase activity.
- G135 (= G177) mutation to A: Very low catalytic efficiency.; mutation to S: Loss of aspartokinase activity.
- R150 (= R192) mutation to A: Significant decrease in the catalytic efficiency.
- D154 (≠ N196) mutation to A: Significant decrease in the catalytic efficiency. Requires higher concentration of magnesium ion than wild-type.; mutation to N: Significant decrease in the catalytic efficiency. Requires higher concentration of magnesium ion than wild-type.
- D174 (≠ H216) mutation to A: Significant decrease in the catalytic efficiency.
- D182 (≠ N224) mutation to A: Significant decrease in the catalytic efficiency.Requires higher concentration of magnesium ion than wild-type.
5yeiC Mechanistic insight into the regulation of pseudomonas aeruginosa aspartate kinase (see paper)
29% identity, 42% coverage: 3:337/803 of query aligns to 4:288/397 of 5yeiC
Sites not aligning to the query:
P26512 Aspartokinase; Aspartate kinase; EC 2.7.2.4 from Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / BCRC 11384 / CCUG 27702 / LMG 3730 / NBRC 12168 / NCIMB 10025 / NRRL B-2784 / 534) (see 2 papers)
27% identity, 47% coverage: 3:378/803 of query aligns to 5:349/421 of P26512
- G277 (= G316) mutation to A: Change in the inhibitory profile upon addition of threonine.
- A279 (≠ D318) mutation to V: Absence of inhibition upon addition of threonine and lysine or lysine alone.
- Q298 (= Q337) mutation to A: Change in the inhibitory profile and absence of dimerization upon addition of threonine.
- S301 (≠ G338) mutation to F: Absence of inhibition upon addition of threonine and lysine or lysine alone.; mutation to Y: Feedback-resistant and enhanced expression of the asd gene.
Sites not aligning to the query:
- 360 V→A: Change in the inhibitory profile and shows an different oligomer state upon addition of threonine.
- 361 T→A: Change in the inhibitory profile and absence of dimerization upon addition of threonine.
- 363 E→A: Change in the inhibitory profile and absence of dimerization upon addition of threonine.
- 364 F→A: Change in the inhibitory profile and shows an different oligomer state upon addition of threonine.
P41398 Aspartokinase; Aspartate kinase; EC 2.7.2.4 from Corynebacterium flavescens (see paper)
27% identity, 47% coverage: 3:378/803 of query aligns to 5:349/421 of P41398
- D345 (≠ N374) mutation to G: Decreased sensitivity of AK activity to concerted feedback inhibition by lysine and threonine.
Query Sequence
>WP_066328676.1 NCBI__GCF_900100165.1:WP_066328676.1
MKILKFGGKSLSNGEGINKVVSIITDKVNQGEKIAIVVSARGNATDELEEILAVASKNAD
YKSLLEQFKKYQQDVYANVDLSEEFAVLDKLFEGVSLIGDYSSKIKDQILSIGELLSAKL
LTAILVEKGVNARFADSRTFLKTDSKFGDAQPLEQVSKKNVIKYFKDNDDAVNVVTGFIG
SNINNVTTTLGRNGSNYTASLLANYLDAKELQNYTHVDGIYTANPDLVADAKKIDHLTFN
EANELANFGATILHAKTIIPLLEKNIPLRILNTFNHENEGTLITATSKSGGIKTLSVLED
LALVNLEGRGLLGKTGVDARIFKVMGDNNISVSIISQGSSERGIGLVVAESQATKAMIEL
EKEFENDFYSKDVNKISVTDDVSVISIIGQDLSTFYRPYTALIKNKIIPILFNNTVTGKN
VSLVVKKSELNKALNVIHGEIFGVSKKINIAVFGHGLVGGTLINQILESAKAIEKRKDIK
LNIFAIANSKNVLLNKDGVSPNWVNEIQTNGFAYTIKDVIAYANENHLENLIAVDNTASA
AFVENYIPLVENGFDLISSNKVANTLSYGFYKELRKVLAENQKNYLYETNVGAGLPLIDT
IKLLHLSGENITKIKGVFSGTLSYLFNNFSAKDAPFSDILKEAIDNGYTEPDPREDLCGN
DVGRKLLILARELDLQNEFEEIAIQNLIPEHLREGSAADFLTKLKEFDPIYTKIKEEQKP
NHVLRYIGELSGDLQNDKGILEVKLVSVPSDTALGGLKGSDSFFEIYTESYGDRPIVIQG
AGAGSAVTARGVFGDILRLSDKG
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory